LRMR
Larimar Therapeutics Inc.
$3.89
-$0.15(-3.71%)
43
Overall
60
Value
27
Tech
--
Quality
Market Cap
$359.48M
Volume
1.13M
52W Range
$1.61 - $9.50
Target Price
$16.70
EPS Estimates Overview
| Current Quarter | $-0.38 | Next Quarter | $-0.39 |
| Current Year | $-1.63 | Next Year | $-1.49 |
| QoQ Growth | -2.6% | YoY Growth | +8.6% |
| 3Y EPS CAGR | +23.5% | Target Price | $16.70 |
| Consensus | Buy | Upside | +329.3% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | LRMR | $3.89 | -3.7% | 1.13M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Larimar Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW